<code id='9951B21962'></code><style id='9951B21962'></style>
    • <acronym id='9951B21962'></acronym>
      <center id='9951B21962'><center id='9951B21962'><tfoot id='9951B21962'></tfoot></center><abbr id='9951B21962'><dir id='9951B21962'><tfoot id='9951B21962'></tfoot><noframes id='9951B21962'>

    • <optgroup id='9951B21962'><strike id='9951B21962'><sup id='9951B21962'></sup></strike><code id='9951B21962'></code></optgroup>
        1. <b id='9951B21962'><label id='9951B21962'><select id='9951B21962'><dt id='9951B21962'><span id='9951B21962'></span></dt></select></label></b><u id='9951B21962'></u>
          <i id='9951B21962'><strike id='9951B21962'><tt id='9951B21962'><pre id='9951B21962'></pre></tt></strike></i>

          Home / Wikipedia / leisure time

          leisure time


          leisure time

          author:explore    Page View:44
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In